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As New Year’s resolutions fall slowly by the wayside and those jogging shoes gather dust, this
issue’s Select gives you the motivation to keep going with two new papers that reveal the benefits
of exercise. We also join the debate about the cause of a common form of muscular dystrophy and
find out why, for some individuals (and mice), the heat of a workout could spell sudden death.The Greek goddess Iris.From: Muscle. You Have One New Message
The long-term benefits of exercise for the muscular system are relatively well under-
stood. Inmice,activemuscles turnonaprogramofgeneexpressiondrivenbythe tran-
scription factor PGC1-a, which boosts production of mitochondria and encourages
the formation of new blood vessels, increasing the muscle’s ability to respond to
increasedworkload.However, exercise alsopromotes ahost of other changesacross
the whole body that aremore difficult to explain. In fact, simply increasing expression
of PGC1-a in mouse muscle is sufficient to induce many of these changes, including
enhanced resistance to bothdiabetes and age-related obesity and extended lifespan.
How is it that the musculature can exert such a powerful global influence onmetabo-
lism? Bostro¨m et al. (2012) now identify a new hormone that is released by muscle
under conditions of regular exercise. The hormone, which they named irisin after the
Greekmessengergoddess Iris, actson subcutaneous fat deposits to stimulate energy
consumption. It does this by causing white fat cells to take on characteristics of
thermogenic brown fat. Brown adipose tissue expends energy by metabolizing lipidand glucose to generate heat rather than ATP. This presents a paradox: what is the benefit of wasting energy to generate heat
in conditions inwhichATPdemanddue to exercise is increased? It is possible that themechanismoriginally evolvedas a response
to the cold; muscle activity from shivering would trigger additional heat production from the adipose tissues.
The effect of irisin on energy consumption may, however, have an unexpected payoff for modern humans. ‘‘Browning’’ of
white adipose tissue by genetic manipulation of the differentiation program has previously been shown to improve glucose
homeostasis, so the authors tested whether injecting mice with a viral vector carrying the irisin gene would have a similar
effect. Remarkably, even though thesemice display relatively modest increases in circulating irisin levels, the treatment signif-
icantly improves glucose tolerance in mice fed a high-fat diet. Their results raise hopes that the hormone may provide ther-
apeutic benefits for the treatment of type II diabetes and obesity in humans and could be particularly valuable for patients who
are otherwise unable to exercise. It remains to be discovered how irisin signals to its target cells, but identification of the irisin
receptor may be the next step toward identifying other target tissues for this exciting new hormone.
Bostro¨m, P., et al. (2012). Nature 481, 463–468.Fura-2 imaging reveals resting Ca2+ levels in
muscle fibers of Ryr1 mutant mice. AICAR
(right) prevents high temperature-induced
calcium influx (bottom).Keep Cool and Carry On
Burningoffexcesscaloriesat thegymmaybeagreat idea formany reasons,but that
might notbe thecase if you’reoneof the rare individualswith agenetic susceptibility
to heat stroke or malignant hyperthermia, a condition that renders sufferers hyper-
sensitive to extremes in temperature and exposure to inhalation anesthetics. In
some individuals, exposure to these triggers can result in a potentially fatal collapse
of themuscular system, characterizedbywhole-body contractions andbreakdown
ofmuscle fibers.Malignant hyperthermia belongs to a family of diseases causedby
mutations in the ryanodine receptorgene,RYR1.Affected individualsareoften iden-
tified only by chance in the operating theater upon being treatedwith general anes-
thetics. In these circumstances, the symptoms can be readily reversed by rapid
administration of the muscle relaxant dantrolene. If the response is triggered by
elevated environmental temperatures, however, the cause of collapse may not be
identified until it is too late. Thus, there is considerable interest in identifying drugs
that could prevent the attacks from occurring in the first place.
Using a mouse model of malignant hyperthermia carrying a Ryr1 mutation equivalent to that found in the human disease,
Lanner and coworkers identify a candidate prophylactic treatment for enhanced susceptibility to heat stroke. Heterozygous
mutant mice die suddenly with heat stroke-like symptoms when exposed to temperatures above 37C or when exercising
at temperatures above 25C. Strikingly, mice treated with the AMPmimic AICAR are protected. AICAR is perhaps best known
as an activator of the metabolic enzyme AMPK, but in this case, the authors rule out a role for AMPK in prevention of
heat-induced response. Instead, AICAR seems to act directly on the mutant ryanodine receptor, plugging a calcium leak thatCell 148, February 17, 2012 ª2012 Elsevier Inc. 629
could underlie the patients’ sensitivity to heat. AICAR has previously been reported to behave as an exercise mimetic that
enhances muscle performance and thus may be an excellent candidate for future clinical investigation.
Lanner, J.T., et al. (2012). Nat. Med. Published online January 8, 2012. 10.1038/nm.2598.Cultured FSHD skeletal muscle shows a rare burst
of DUX4 protein expression (red) in the nucleus of
a myofiber (blue DAPI, green myosin). Photograph
by Linda Geng.Muscular Dystrophy Gene DUX Detection
In a world of complex diseases, whole-genome sequencing, and genome-
wide association studies, you could be forgiven for thinking that the cata-
loging of humanity’s monogenic disorders will soon be relegated to the
work of undergraduate students and robots. But the identification of disease
genes is not always simple. The mutation that causes one of the most
common forms of muscular dystrophy, fascioscapulohumeral dystrophy
(FSHD), was first identified nearly 20 years ago. But since then, identifying
the gene whose expression is modified by this mutation has proven to be
more challenging. Themost common variant of the disease, FSHD1, is asso-
ciated with loss of a chunk of subtelomeric macrosatellite repeats: affected
individuals tend to have fewer than 10 of these repeats remaining, whereas
unaffected individuals may have as many as 100 in the same location.
Each repeat contains a single copyof theDUX4 retrogene, andbecausedele-
tion of repeats was shown to be associated with decreased levels of repres-
sive epigenetic marks in the region, it has been proposed that inappropriateexpression of this transcription factor is responsible for FSHD1. However, DUX4 mRNA is not reliably detected in FSHD
muscle, leading many to focus on other genes in the region as potential disease candidates.
Geng et al. (2012) now provide evidence that DUX4 may, in fact, be the gene responsible after all. Rather than look for
expression of DUX4 itself, they reasoned that detection of its downstream transcriptional targets might provide a more sensi-
tive readout for DUX4 activity. They identify a cohort of genes with DUX4-binding sites that are upregulated in myoblasts ex-
pressing DUX4 and find that the same cohort of genes displays elevated expression in FSHD muscle cultures and biopsies
compared with cultures and biopsies derived from unaffected individuals. Not only do the findings support a role for DUX4
activity in FSHD pathology, they also provide some insight into the downstream consequences of DUX4 expression. DUX4
targets are enriched in genes associated with the germline and innate immunity, and it will be interesting to test whether these
targets play any role in the immunopathology that can accompany FSHD.
Geng, L.N., et al. (2012). Dev. Cell 22, 38–51.The treadmill route to boosting autophagy.Exercising Autophagy
Hungry cells are well known to resupply their dwindling reserves of energy by
digesting their intracellular contents, enclosing whole swathes of cytoplasm
and organelles in a double-membrane structure, the autophagosome, which
isdelivered to the lysosome fordestruction.Recent yearshavedemonstrated
that autophagy, rather than acting as a simple waste disposal system, plays
an integral part in cellular homeostasis, serving a generally protective func-
tion in diabetes, cancer, infection, and neurodegenerative disease. Recent
work by He et al. (2012) now extends the repertoire of autophagy to include
an important role in mediating some of the beneficial effects of exercise. In
mice trained on a treadmill, exercise promotes autophagy not only inmuscle,
but also in a number of other tissues, including liver and pancreas.
Totest the functionof thiswidespreadupregulation, theyconstructedamutant
mouse that exhibits normal levels of basal autophagybut is unable to upregulate
autophagy in response to physiological triggers such as starvation. This was
achieved by inactivating three phosphorylation sites in the BCL2 gene. The resulting BCL2-AAA mice are viable and fertile and
have histologically normal muscles, but they fail to display increased autophagy in response to exercise. In the absence of exer-
cise-induced autophagy, the mice are less able to endure sustained physical exertion, and unlike control mice, their muscles do
not respond to exercise by increasing plasmamembrane targeting of the glucose uptake channel GLUT4. Most tellingly, although
feedingwithahigh-fatdiet impairsglucose toleranceand increases levelsof serumtriglyceridesandcholesterol toasimilar extent in
both theBCL2-AAAmiceand thecorrespondingcontrols, these impairmentsarecounteredbyexercise incontrol animals,butnot in
themutants.Althoughadditional effectsof theBCL2-AAAmutationcan’tbe ruledout, it thereforeseems likely thatexercise-induced
autophagy is required tomediate the beneficial effects of physical exertion onmetabolism. How it does this remains amystery that
will no doubt exercise the minds of those in the Levine lab and beyond.
He, C., et al. (2012). Nature 481, 511–515.
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